Viking Therapeutics (VKTX) Misses Q3 EPS by 11c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.81), $0.11 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Copart (CPRT) call put ratio 1.8 calls 1 put a share price up 3.9%
• John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance